A Rare Case Report on Cervical Carcinosarcoma, Clinical Presentation and Treatment Outcome

Abstract Cervical carcinosarcoma (CCS) also known as malignant mixed mesodermal tumor (MMMT) is a rare aggressive biphasic tumor which has high grade epithelial and mesenchymal components. Carcinosarcomas occur most frequently in uterine corpus, can also arise in ovaries, cervix, fallopian tubes, vagina, peritoneum, and extra genital sites. The Cancer Genome Atlas (TCGA) data supports conversion and combination theories where carcinomatous cells convert themselves in sarcomatous via epithelial to mesenchymal transition. Currently there has been no consensus regarding survival, management and prognosis of CCS. Here we report a case of a perimenopausal female with abnormal uterine who was diagnosed preoperatively on biopsy as poorly differentiated carcinoma, was taken for radical hysterectomy and was diagnosed on final histopathology as carcinosarcoma of cervix.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-09-20
DOI
https://doi.org/10.5281/zenodo.13821559
Primary Topic
Uterine Myomas and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Rare Case Report on Cervical Carcinosarcoma, Clinical Presentation and Treatment Outcome

Zenodo (CERN European Organization for Nuclear Research)
Uterine Myomas and Treatments
article

A Rare Case Report on Cervical Carcinosarcoma, Clinical Presentation and Treatment Outcome

article en

Abstract

Abstract Cervical carcinosarcoma (CCS) also known as malignant mixed mesodermal tumor (MMMT) is a rare aggressive biphasic tumor which has high grade epithelial and mesenchymal components. Carcinosarcomas occur most frequently in uterine corpus, can also arise in ovaries, cervix, fallopian tubes, vagina, peritoneum, and extra genital sites. The Cancer Genome Atlas (TCGA) data supports conversion and combination theories where carcinomatous cells convert themselves in sarcomatous via epithelial to mesenchymal transition. Currently there has been no consensus regarding survival, management and prognosis of CCS. Here we report a case of a perimenopausal female with abnormal uterine who was diagnosed preoperatively on biopsy as poorly differentiated carcinoma, was taken for radical hysterectomy and was diagnosed on final histopathology as carcinosarcoma of cervix.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 48%
Uterine Myomas and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.